XML 54 R39.htm IDEA: XBRL DOCUMENT v3.25.0.1
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Stock Options and Stock Appreciation Rights (SARs)  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Valuation Assumptions
The following table illustrates the assumptions used in estimating fair value in the years ended December 31, 2024, 2023 and 2022:

202420232022
Grant date fair value of stock options and SARs$33.04 $40.18 $49.88 
Expected stock price volatility43.01 %41.84 %38.45 %
Risk-free interest rate4.21 %4.14 %1.68 %
Expected annual dividend yield1.00 %0.82 %0.56 %
Expected life of options and SARs (years)
5.55.45.4
Schedule of Stock Option and SAR Activity
The following table illustrates the stock option and SAR activity for the year ended December 31, 2024:

Number
of
Shares
(in 000’s)
Weighted-
Average
Exercise
Price
Outstanding at December 31, 20233,764 $93.82 
Granted687 $79.39 
Forfeited(358)$100.21 
Exercised(223)$52.98 
Outstanding at December 31, 20243,870 $93.00 
Exercisable at December 31, 20242,280 $86.40 
Stock options & SARs expected to vest 1,590 $102.46 
Restricted Stock Units (RSUs) and Performance Share Units (PSUs)  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of PSU and RSU Activity
The following table illustrates the RSU and PSU activity for the year ended December 31, 2024:  

Number
of
Shares
(in 000’s)
Weighted-
Average
Grant-Date
Fair Value
Outstanding at December 31, 202367 $129.32 
Granted91 $95.80 
Vested(16)$114.17 
Forfeited(12)$107.81 
Outstanding at December 31, 2024130 $109.59